205 related articles for article (PubMed ID: 14988509)
1. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.
Nagai T; Yamada K; Yoshimura M; Ishikawa K; Miyamoto Y; Hashimoto K; Noda Y; Nitta A; Nabeshima T
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3650-5. PubMed ID: 14988509
[TBL] [Abstract][Full Text] [Related]
2. [Role of tissue plasminogen activator in the rewarding effect of morphine].
Nagai T; Nabeshima T; Takuma K; Yamada K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Feb; 41(1):23-30. PubMed ID: 16619846
[TBL] [Abstract][Full Text] [Related]
3. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system.
Ito M; Nagai T; Mizoguchi H; Fukakusa A; Nakanishi Y; Kamei H; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Jun; 101(5):1392-9. PubMed ID: 17286591
[TBL] [Abstract][Full Text] [Related]
5. [Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse].
Nagai T; Takuma K; Nabeshima T; Yamada K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):1-6. PubMed ID: 18411702
[TBL] [Abstract][Full Text] [Related]
6. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice.
Nagai T; Kamei H; Ito M; Hashimoto K; Takuma K; Nabeshima T; Yamada K
J Neurochem; 2005 Jun; 93(5):1272-9. PubMed ID: 15948318
[TBL] [Abstract][Full Text] [Related]
7. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
[TBL] [Abstract][Full Text] [Related]
8. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
[TBL] [Abstract][Full Text] [Related]
9. [Role of tissue plasminogen activator in the rewarding effect of nicotine].
Nagai T; Yamada K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):151-7. PubMed ID: 18646640
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of plasminogen activators in the nucleus accumbens enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization.
Bahi A; Dreyer JL
Genes Brain Behav; 2008 Mar; 7(2):244-56. PubMed ID: 17680802
[TBL] [Abstract][Full Text] [Related]
11. Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice.
Yan Y; Yamada K; Mizoguchi H; Noda Y; Nagai T; Nitta A; Nabeshima T
Neuroscience; 2007 Apr; 146(1):50-9. PubMed ID: 17317018
[TBL] [Abstract][Full Text] [Related]
12. The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1.
Nagai T; Ito M; Nakamichi N; Mizoguchi H; Kamei H; Fukakusa A; Nabeshima T; Takuma K; Yamada K
J Neurosci; 2006 Nov; 26(47):12374-83. PubMed ID: 17122062
[TBL] [Abstract][Full Text] [Related]
13. Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling.
Ito M; Nagai T; Mizoguchi H; Sato K; Hayase M; Otsuka N; Fukakusa A; Kumagai N; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Dec; 103(6):2589-96. PubMed ID: 17944865
[TBL] [Abstract][Full Text] [Related]
14. Involvement of tissue plasminogen activator "tPA" in ethanol-induced locomotor sensitization and conditioned-place preference.
Bahi A; Dreyer JL
Behav Brain Res; 2012 Jan; 226(1):250-8. PubMed ID: 21945298
[TBL] [Abstract][Full Text] [Related]
15. Basic and translational research on proteinase-activated receptors: regulation of nicotine reward by the tissue plasminogen activator (tPA) - plasmin system via proteinase-activated receptor 1.
Nagai T; Nabeshima T; Yamada K
J Pharmacol Sci; 2008 Dec; 108(4):408-14. PubMed ID: 19098386
[TBL] [Abstract][Full Text] [Related]
16. Drug dependence, synaptic plasticity, and tissue plasminogen activator.
Yamada K; Nagai T; Nabeshima T
J Pharmacol Sci; 2005 Feb; 97(2):157-61. PubMed ID: 15684570
[TBL] [Abstract][Full Text] [Related]
17. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization.
Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Noda Y; Nabeshima T
Biol Psychiatry; 2007 Sep; 62(6):658-68. PubMed ID: 17217924
[TBL] [Abstract][Full Text] [Related]
19. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF
J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
[TBL] [Abstract][Full Text] [Related]
20. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
